Current approaches to the treatment of Parkinson’s disease
Open Access
- 1 September 2008
- journal article
- review article
- Published by Informa UK Limited in Neuropsychiatric Disease and Treatment
- Vol. 4 (4), 743-757
- https://doi.org/10.2147/ndt.s2006
Abstract
Dove Press is a member of the Open Access Initiative, specializing in peer reviewed Medical Journals. View articlesor submit your research for publishingKeywords
This publication has 109 references indexed in Scilit:
- Double‐blind, randomized, controlled trial of rasagiline as monotherapy in early Parkinson's disease patientsMovement Disorders, 2004
- Comparison of the Risk of Adverse Events with Pramipexole and Ropinirole in Patients with Parkinson???s DiseaseDrug Safety, 2003
- Treatment of Psychosis in Parkinson???s DiseaseDrug Safety, 2003
- Apathy in Parkinson's diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2002
- Apomorphine monotherapy in the treatment of refractory motor complications of Parkinson's disease: Long‐term follow‐up study of 64 patientsMovement Disorders, 2002
- Donepezil in the treatment of hallucinations and delusions in Parkinson’s diseaseNeurological Sciences, 2002
- Are Dopamine Receptor Agonists Neuroprotective in Parkinson??s Disease?Drugs & Aging, 2001
- Tolcapone and fulminant hepatitisThe Lancet, 1998
- Selegiline in de novo parkinsonian patients: The French selegiline multicenter trial (FSMT)Acta Neurologica Scandinavica, 1991
- Antiparkinsonian and antidepressant effects of high doses of bromocriptine: An independent comparisonJournal of Affective Disorders, 1983